Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:JAN

JanOne (JAN) Stock Price, News & Analysis

JanOne logo

About JanOne Stock (NASDAQ:JAN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$1.90
$3.49
52-Week Range
N/A
Volume
139,500 shs
Average Volume
229,417 shs
Market Capitalization
$20.03 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. It operates through Biotechnology and Recycling segments. The company's lead product candidate is JAN101, a patented oral and sustained release pharmaceutical composition of sodium nitrite that targets poor blood flow to the extremities in patients with diabetes or peripheral artery disease to treat pain. It also provides turnkey appliance recycling and replacement services for utilities and other sponsors of energy efficiency programs. The company was formerly known as Appliance Recycling Centers of America, Inc. and changed its name to JanOne Inc. in September 2019. JanOne Inc. was founded in 1976 and is headquartered in Las Vegas, Nevada.

Receive JAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for JanOne and its competitors with MarketBeat's FREE daily newsletter.

JAN Stock News Headlines

A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
See More Headlines

JAN Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that JanOne investors own include Meta Platforms (META), NVIDIA (NVDA), Teradyne (TER), Salesforce (CRM), DraftKings (DKNG), FuboTV (FUBO) and MARA (MARA).

Company Calendar

Today
5/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:JAN
Employees
170
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$7.81 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$39.61 million
Price / Cash Flow
N/A
Book Value
($0.67) per share
Price / Book
N/A

Miscellaneous

Free Float
8,707,000
Market Cap
$20.03 million
Optionable
Not Optionable
Beta
2.16
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (NASDAQ:JAN) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners